Showing 1601-1610 of 8793 results for "".
Creative Social Network Engagement to Boost Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/creative-social-network-engagement-to-boost-your-dermatology-practice/21540/Creative social media promotion can achieve the greatest impact and widespread publicity for the dermatologist—at the lowest cost.Your EHR Server: Cloud vs. Hosted
https://practicaldermatology.com/topics/practice-management/your-ehr-server-cloud-vs-hosted/21606/While EHRs are shifting to cloud-based servers, clinicians should consider how each model suits their individual needs.Take 5: Developments Toward Improved Skin Cancer Detection and Treatment
https://practicaldermatology.com/columns/take-5/take-5-developments-toward-improved-skin-cancer-detection-and-treatment/21895/Here's an update on various studies and developments regarding the management of cutaneous malignancies.Take 5: Promising Developments in Vitiligo Research
https://practicaldermatology.com/columns/take-5/promising-developments-in-vitiligo-research/21924/New studies suggest therapeutic pearls for the management of vitiligo and highlight new approaches to understanding the disorder.Take 5: Recent Developments in Dermatologic Laser Therapy
https://practicaldermatology.com/columns/recent-developments/recent-developments-in-dermatologic-laser-therapy/21936/Research continues to highlight the benefits of lasers for cosmetic as well as medical complaints.Take 5: Summer Skin Care Pearls to Share with Patients
https://practicaldermatology.com/columns/take-5/take-5-summer-skin-care-pearls-to-share-with-patients/21984/As summer approaches, here are five points you could mention to your patients about UV protection.Clinical Focus: Psoriasis: New Data on Comorbidities Associated with Psoriasis
https://practicaldermatology.com/topics/psoriasis/new-data-on-comorbidities-associated-with-psoriasis/21979/With data mounting, it is essential that dermatologists monitor all patients who may be at risk for comorbidities and provide referrals when indicated.Take 5: Strategies to Fight Skin Cancer Trends
https://practicaldermatology.com/columns/take-5/take-5-strategies-to-fight-skin-cancer-trends/22035/On the 25th anniversary of the renowned ABCDE's of Melanoma, a contributor to the guidelines shares strategies to improve detection and bolster prevention efforts.GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muGLP-1RAs and the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1ras-and-the-dermatologist/48885/We are only beginning to understand the implications of GLP-1s for skin and systemic health. These medications are here to stay, and dermatology must be part of the conversation.